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ABSTRAK 
Keberkesanan Diabetes Conversation Map™ dalam penerimaan rawatan insulin di 
kalangan pesakit diabetis jenis 2 yang menolak rawatan insulin. 
Latar Belakang: Pendidikan kesihatan merupakan komponen penting di dalam perawatan pesakit 
diabetis. Ia boleh diberikan sama ada secara berkumpulan atau pun individu. Bagi   klinik kesihatan 
yang agak sibuk, pendidikan kesihatan secara berkumpulan dilihat lebih praktikal untuk 
dilaksanakan. Namun demikian, kebanyakan klinik kesihatan pada masa kini dilihat masih kurang 
mempraktiskan pendidikan kesihatan secara berkumpulan. Baru-baru ini, pihak “International 
Diabetic Federation” telah telah mengambil inisiatif dengan memperkenalkan Diabetes 
Conversation Map (DCM) iaitu modul pendidikan kesihatan yang dikendalikan secara 
berkumpulan. Modul ini telah digunakan di beberapa negara termasuk Malaysia.  Modul ini telah 
dialih bahasa ke bahasa melayu. Ini menyebabkan penggunaannya semakin meluas. 
Walaubagaimanapun, keberkesanan penggunaan modul ini masih tidak diketahui di negara kita. 
Objektif: Untuk mengetahui peratusan pesakit yang bersetuju menerima insulin di antara 
kumpulan intervensi iaitu yang diberikan pendidikan kesihatan menggunakan DCM dengan 
kumpulan kawalan iaitu yang diberikan pendidikan secara individu mengikut modul standard dan 
faktor-faktor berkaitannya di kalangan pesakit diabetes jenis 2 yang tidak terkawal yang menolak 
rawatan insulin yang menghadiri klinik rawatan keluarga HUSM. 
Kaedah: Sejumlah 88 pesakit yang menghidap diabetes mellitus jenis 2 dan mempunyai Hba1c 8 
% dan keatas yang datang ke klinik rawatan keluarga Hospital USM telah terlibat dengan 
penyelidikan ini. Mereka dibahagikan secara terkawal kepada dua kumpulan iaitu kumpulan 
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intervensi iaitu yang menerima pendidikan kesihatan secara berkumpulan menggunakan DCM 
manakala kumpulan terkawal adalah yang menerima pendidikan secara individu mengikut modul 
standard. Selepas sesi intervensi, pesakit akan ditemubual oleh penyelidik untuk mengetahui 
penerimaan mereka terhadap permulaan insulin. Analisa regresi logistik telah dilakukan untuk 
mencari faktor-faktor yang berkaitan dengan penerimaan insulin. 
Keputusan: Kadar responden adalah 97.7%. Kumpulan intervensi menunjukkan penerimaan 
insulin yang lebih tinggi berbanding dengan kumpulan kawalan (86% berbanding 11%, p < 0.001). 
Daripada analisis regresi logisik berganda, didapati faktor yang berkaitan dengan penerimaan 
insulin adalah sejarah pesakit yang menpunyai ahli keluarga yang menggunakan insulin (AOR: 
6.96; 95% CI: 2.30, 21.03; p=0.001). 
Kesimpulan: Pendidikan kesihatan secara berkumpulan menggunakan Diabetic Conversation 
MAP (DCM) menunjukkan penerimaan yang signifikan untuk memulakan insulin berbanding 
dengan pendidikan standard secara individu. Penggunaan insulin dikalangan ahli keluarga pesakit 
merupakan  faktor berkaitan yang signifikan terhadap penerimaan insulin. Dengan ini, DCM 
disarankan untuk digunakan secara meluas di pusat kesihatan primer bagi membantu pesakit yang 
tidak mahu menerima rawatan insulin pada awalnya untuk memerima rawatan insulin bagi 
memastikan tahap kencing manis pesakit berada dalam keadaan terkawal. 
Kata kunci: diabetes mellitus jenis ke 2; Diabetic Conversation Map; pendidikan kesihatan 
berkumpulan; pendidikan secara individu; insulin;  
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ABSTRACT 
Effectiveness of Diabetes Conversation Map™ on insulin acceptance among Type 
2 Diabetes Mellitus insulin refusal patients. 
Background: Diabetes education is a very crucial aspect of management for a diabetic patient. 
Educations can be delivered either by group or individual. For busy health centres, group education 
is the most practical approach in the setting. However, in most of the public hospital setting, the 
group-based diabetes education is still not yet well established. In recent years, group-based 
diabetes education using the diabetes conversation maps (DCM) endorsed by the International 
Diabetes Federation has been popularised ever since the complete set was translated into malay 
language. However, the effectiveness of this diabetes conversation map is still not known in our 
country. 
Objectives: To compare the percentage of insulin acceptance between the intervention group 
(those who receive DCM education) and control group (those who receive standard counselling) 
and associated factors of insulin acceptance among uncontrolled type 2 diabetic patients, who 
refused insulin initiation attending Klinik Rawatan Keluarga HUSM. 
Methodology: An interventional study was carried out where a total of 88 Type 2 diabetic adults 
from Klinik Rawatan Keluarga, HUSM with glycosylated haemoglobin (HbA1c) concentrations of 
8% and or more and refused insulin treatment were randomised into intervention(those who 
receive DCM education) and control groups(those who receive standard individual education). 
Post sessions, participants were reviewed by the investigator to find out their acceptance towards 
insulin initiation. Logistic regression was done to look at the factors associated with the insulin 
acceptance. 
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Results: The response rate was 97.7%. There was a significant difference in insulin acceptance 
between the intervention group education using DCM as compared to the control group using 
standard individual education module (86% vs 11%, p < 0.001). There was a significant association 
between history of relatives use insulin and insulin acceptance (AOR: 6.96; 95% CI: 2.30, 21.03; 
p=0.001). 
Conclusion: Group education using Diabetes Conversation Map (DCM) is effective in increasing 
insulin acceptance among patient who initially refused insulin treatment. We recommend using 
DCM in primary care centres for diabetic patients who had difficulties in accepting insulin. Having 
relative that use insulin is a significant associated factor among patient who accepts insulin. 
Keyword: type 2 diabetes; acceptance; insulin; group education; individual education 
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CHAPTER 1: INTRODUCTION  
1.1 Overview of Diabetes Mellitus    
            Diabetes Mellitus is a very common chronic disease and a condition that is so far no known 
cure has been found. It has a considerable impact on the life of each individual patient and 
community at large as well health and economic burden to the country (MOH, 2015). It is a 
metabolic disorder that is characterised by high glucose levels in the blood that causing many 
metabolic disorders. In many instances, this condition is due to the insulin resistance whereby the 
insulin produced did not function as effectively as it should be. The insulin resistance will lead to 
insulin deficiency eventually.  
          Another important factor is increasing production of glucose by the liver (MOH, 2015). Not 
enough insulin or the inability of the body to respond will leads to high levels of blood glucose, or 
hyperglycemia, which is the main problem in diabetes (Forbes and Cooper, 2013). Hyperglycemia, 
if left untreated over the long term, will cause damage to many body organs, leading to the 
development of serious health complications such as myocardial infarction, stroke, kidney failure, 
an eye disease that can lead to blindness. 
1.2 Prevalence of Diabetes Mellitus Worldwide and Malaysia 
               Diabetes Mellitus is well recognised as an important global health problem. The 
incidence of diabetes, as well as the prevalence, are escalating more so in developing and newly 
industrialised countries. In Malaysia, according to a survey done, National Health and Morbidity 
Survey (NHMS) 2015, the prevalence of diabetes mellitus (known and undiagnosed) among adults 
between 20 to 79 years old was 17.5% compared to study done in 2011 where the figure was 15.2% 
(2.6 million) ((NHMS), 2015) . According to US Centres for disease control and prevention 
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estimates that one in three people in the United States may develop diabetes in the year 2050 
(Seaquist, 2014). However the latest facts from International Diabetes Federation, it is estimated 
that 1 in 11 adults has diabetes and the prevalence of Diabetes in Malaysia in 2017 is 17.9 
(Federation, 2017). This shows a rise in the number of diabetes patients and optimisation of the 
treatment is important in reducing global health expenditure in future. 
1.3 Uncontrolled Diabetes         
1.3.1 Definition of Uncontrolled Diabetes 
              Clinically uncontrolled diabetes is defined base on their Hba1c level. We know that poor 
glycaemic controlled give rise to complications. Therefore good glycaemic control is crucial in 
preventing diabetic morbidity and mortality. The level of HbA1c gives an indication of the level 
of glycaemic control of diabetic patients during the previous two to three month duration 
(Jeffcoate, 2004). According to the American Diabetes Association (ADA), they recommended a 
HbA1c goal of less than 7 % while according to the American Association of Clinical 
Endocrinology, they recommended HbA1c of less than 6.5% to be considered in optimal control 
(Association, 2017; endocrinology, 2015) . According to a study, the Diabetes Expert Panel and 
Committee of Performance Measurement (CPM) have concluded that HbA1c > 9% is an indicator 
of poor diabetes controlled (Quality and (NCQA). 2009).  
               In Malaysia, as stated in the clinical practised guideline on management of type 2 
Diabetes Mellitus, a patient who are not approaching targets of Hba1c<6.5% after three to six 
month of optimal treatment involving combination therapy of oral medication, insulin should be 
initiated as soon as possible. It also stated after insulin has been started, it is advisable to repeat 
back Hba1c at 3-4 month later.  
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              Certain changes in HbA1c levels and the HbA1c level at a different point in time will 
possibly give different implications to the patient and managing clinician. In a study, where the 
association between HbA1c and complications were explored, the risks to get the complications 
increased significantly in which  with every 1 % increment level of HbA1c, there is an increased 
risk of 38% in macrovascular event, a 40 % increased risk in microvascular event and a 38 % 
increased risk in death ( all p <0.0001) (Zoungas et al., 2012).  
1.3.2 Prevalence of Uncontrolled Diabetes   
              According to National Diabetes Registry in Malaysia, in 2012, 23.8% of diabetic patient 
achieved the target of HbA1c < 6.5% while mean HbA1c in that year was 8.1%  comparing in 
2015 only 22% of people with T2DM achieved HbA1c target of < 7%  ((NHMS), 2015). This 
shows that the number of uncontrolled diabetes in Malaysia are quite high. Based on a study 
conducted at the Waianae Coast Comprehensive Health Centre (WCCHC) which serves a 
medically underserved, predominantly Native Hawaiian community on O’ahu found out that more 
than 38% of their diabetic patients had poorly controlled diabetes (HbA1c >10%) (Ko, 2013). 
Moreover, a study done in Urban District of Karachi in Pakistan, prevalence of uncontrolled 
diabetes mellitus among diabetes patients with hbA1c>9% was found to be 38.9% (Siddiqui et 
al.). While a study in south-eastern Iran shows that more than 60% of diagnosed diabetic cases 
had impaired HbA1c at first diagnosed (Najafipour et al., 2015). 
1.3.3 Complications of uncontrolled diabetes        
              As we know, diabetes itself lead to complications. Uncontrolled diabetes may lead to 
early complications involving microvascular such as neuropathy, nephropathy and retinopathy and 
macrovascular complications such as stroke, peripheral arterial disease and coronary artery 
disease. An epidemiological analysis of the UKPDS data noted that with every single point 
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reduction in HbA1c level, there was a decrease in the risk involving microvascular complications 
by 35% reduction (Fong et al., 2003). These complications will subsequently affect the patient's 
quality of life. Quality of life is actually a multidimensional concept pointing to a person's whole 
well-being, which includes psychological, social, and physical health status (Bowling et al., 2003). 
1.3.4 Management of uncontrolled diabetes 
               Generally, management of uncontrolled diabetes should involve all aspects which 
include educations, counselling and medications. Literature has shown that counselling plays an 
important role in diabetes management (Dworatzek et al., 2013). According to Malaysia 
Guidelines, the content of the education given should consist of exercise, diet, medication and 
complications including acute and chronic, self-monitoring blood glucose, foot care, the hazard of 
smoking, and psychosocial approach to diabetes (MOH, 2015). Other than that, the most important 
treatment in an uncontrolled diabetic patients is insulin commencement. Based on our Malaysia 
Guidelines, it is stated that those diabetic patients who have HbA1c of 8% or more should be 
started on insulin in ensuring good glycaemic control (MOH, 2015). 
                 Lagging on starting insulin or delayed in insulin initiation for uncontrolled diabetic 
patient have been found in the various study (Goodall et al., 2009; Nichols et al., 2007; Rubino et 
al., 2007).Studies that are mention  above have concluded that most of the diabetic patients who 
delayed in starting insulin treatment are those who have poor perception towards insulin and this 
is mainly because due to lack of knowledge of insulin itself (Polonsky et al., 2005; Wong et al., 
2011). 
             Various educations tools have been developed in enhancing knowledge to improve 
outcomes of diabetes. Diabetes conversation map (DCM) is one the tool that had been developed 
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many years ago. Each DCM have its own focus topic. In Malaysia, DCM have been introduced 
since year 2000. The Ministry of Health of Malaysia has conducted the training courses on using 
DCM for diabetes nurse educators since the year 2004 and is estimated that around 900 diabetes 
nurse educators have been trained fully on DCM and had been practising it in both primary care 
and hospital-based diabetes care. The impact or effectiveness of the DCM is yet to be known. 
  1.4 Rationale of study 
           Insulin is the ultimate treatment of choice in T2DM patients. However insulin refusal rate 
among T2DM is very high. We were trying to find alternative method of education on this issues 
and noted that DCM is available and already been used in Diabetes Centre HUSM and Klinik 
Rawatan Keluarga HUSM, however we yet do not know the effectiveness of this tool in managing 
T2DM patient especially in those who refuse insulin therapy. In this study, we are using DCM on 
topic initiation insulin treatment as an education tool to increase the knowledge and change the 
perception towards insulin therapy among T2DM insulin refusal patients. As we are using the 
DCM on topic initiation insulin treatment and the DCM mainly focus on insulin therapy facts so 
our primary objective is to see the acceptance on insulin therapy after been educate using the DCM. 
We also try to figure out associated factors of insulin acceptance among these patients, thus we 
will try to overcome this factors if it is significant in managing their disease. 
1.5 Scope of study 
                This study is done among uncontrolled T2DM at Klinik Rawatan Keluarga, University 
Sains Malaysia. This hospital is located in North East Malaysia with tertiary settings. The aim of 
the study is to look for the effectiveness of the DCM as an education tool in enhancing type 2 
diabetic patient who refuse insulin to accept insulin. 
6 
 
CHAPTER 2: LITERATURE REVIEW 
2.1 Education in Diabetes Mellitus management 
        
              Education to patient is part of diabetes mellitus management. According to clinical 
practise guideline of Canadian Diabetes Association, nutrition therapy and education play an 
important role in the treatment of diabetes as it can help in reducing glycated haemoglobin 
(HbA1c) by 1.0% to 2.0%  (Dworatzek et al., 2013). In another study, showed that education to 
diabetic patient give an improvement in the metabolic control (Gallegos et al., 2006). 
             Based on a study by Dr.Sachmechi and his team, they compared HbA1c 6 months after 
diabetes and dietician education in 2 groups and it reveals that among patients who saw the diabetes 
educators and dietician, the mean HbA1c was reduced significantly by 1.02%, from 8.47% to 
7.46% with P value < 0.01 while comparing to control group who did not see the diabetes educators 
or dietician, the mean HbA1c was also reduced by 0.59%, from 7.8% to 7.24% with P value< 0.01) 
(DiabetesInControl.com, 2010). This shows that with education to diabetic patients, the Hba1c 
improve much better compared to without education given. Overall, according to Rurik et all, all 
glycaemic parameters improved after  education in diabetic patients (Rurik et al., 2010) 
             As we know, the diabetes education is very important in improving clinical outcomes. It 
should be given to all diabetic patients regardless of treatment or medications they are on. Diabetes 
education should be delivered by a team of educators. Based on Malaysian guidelines on managing 
type 2 diabetes mellitus, educators can be anyone who is working in the diabetic clinic which 
includes dietician, health education officer, nurses, doctors and others. Reinforcement in 
education, may give the best improvements especially in patient outcomes.   
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                However, any educators will need to have more time and more resources to fulfil the 
needs of a properly structured educational programme to be run smoothly. One study by Loveman 
et al found out that diabetes education needs to have a clear programme in the setting (Loveman 
et al., 2008). 
           There are established Diabetes Resource Centres in most of the government hospitals where 
trained diabetes nurse educators are able to deliver patient-centered diabetes education to 
inpatients and also outpatients. Educations can be delivered either by group or individual 
education. Patient education constitutes an important tool for a better diabetes control and prevents 
the diabetes complications which indirectly reduce the costs of treatment (Rickheim et al., 2002). 
There is not enough evidence at this period of time of what type of education methods are the more 
effective in improving clinical outcomes for diabetic patients.  
           Education in a group has been characterised as an alternative to individual education for 
diabetic patients management in the sense of cost-effective (Mensing and Norris, 2003). Multiple 
studies have addressed out that group education among diabetic patient was equally effective 
compared to individual education at improving diabetes control (Rickheim et al., 2002; Trento et 
al., 2004). A systemic review of 11 studies has concluded that group education for the diabetic 
patient is effective in reducing the HbA1c level, increase knowledge about diabetes, reducing 
blood pressure systolic levels and reducing body weight comparing to individual education. 
(Deakin et al., 2005). 
            Furthermore, a recent meta-analysis study of 21 studies has shown that group education 
gives an improvement in HbA1c level in six months compared to individual education with P-
value 0.001, while in 12 months the P value 0.001 and within 2 years the P-value < 0.001. The 
same study also resulted in significant changes of blood glucose level in 12 months with a P-value 
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< 0.001 and improvement in diabetes knowledge in 6 months was also noted increase with P –
value < 0.001  (Steinsbekk et al., 2012).  
           A study by Hwee et al. supported that, where in the study they compared individual and 
group education and they found out that there were fewer acute complications and some 
improvements in the diabetes care management in laboratory claims for at least two HbA1c 
(glycated hemoglobin) tests, one lipid test and one optometry or ophthalmology claim for a retinal 
screening examination were done for the participants (Hwee et al., 2014). 
2.2 Diabetes Conversation Map (DCM)  
             Diabetes conversation map are an education tools for facilitated group education and are 
designed to engage patients in making changes in behaviour in ensuring good health (Belton, 
2008). DCM are developed by Healthy Interactions in collaboration with the International Diabetes 
Federation (IDF) and are sponsored by Lilly Diabetes. Different DCM versions have been 
developed worldwide in cooperation with national and international diabetes associations (IDF 
and the Canadian, American, and U.K. diabetes associations) to reflect differences in culture and 
background (Belton, 2008; Reaney et al., 2013) 
            DCM is actually a table top visual tools which size about 3 feet by 5 feet and it is designed 
to be used for small interactive groups which usually involve three to ten people. The participants 
in the group will learn about the main topic that is discuss in the DCM. There are many various 
topic available which include; the basic knowledge about diabetes, living with diabetes disease, 
healthy eating in diabetes, how to stay active in diabetes, how to self-monitor blood glucose level, 
common diabetes complications, diabetes in pregnancy, diabetes in ramadan and starting insulin 
treatment.  
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            The first development of the DCM was noted in Canada in the year 2004 where during that 
time, a conversation map was used in the management of business organizations and it was 
observed and they felt that it could be used in health education especially for diabetes patient 
(Belton, 2008). A team of health educators that were chosen by the Canadian Diabetes Association 
try to work with the Healthy Interactions group company to develop the DCM. Two DCM topics 
were developed, one called starting your journey and the other called continuing your journey. 
They had organised few pilot study in different parts of the country and the results were very 
positive and the DCM were officially introduced in the year 2005 to Canadian diabetes educators. 
They noted that the Canadian diabetes educators need to undergone training on how to use the 
DCM. This was because the educators actually need to act as the facilitator who plays an important 
role in the discussion and they might require a different set of skills in ensuring the education been 
delivered successfully (Belton, 2008).  
               Another DCM was produced by Merck® in collaboration with the American Diabetes 
Association (ADA) in the year 2006 in the US. The US DCM consists of five different topics. The 
first DCM gave an overview of diabetes, the second DCM discusses on healthy eating, the third 
DCM highlights on the importance of blood glucose level monitoring and the fourth DCM 
describes the natural progression of diabetes and complications while the fifth DCM provides on 
pregnancy with diabetes.                             
            The Eli Lilly ® Company had launched the DCM in the year 2008, in partnership with 
Healthy Interactions. The DCM topics consist of living with diabetes, how diabetes works, healthy 
eating and keeping active, starting insulin treatment, diabetes in Ramadan and caring of your foot 
(Interactions, 2015) . The DCM that was launched consists of a visual table top with size about 3 
feet by 5 feet together with the “myth” and “fact” cards on the specific topic chosen for the 
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discussion. Example of the content of the cards on the topic starting insulin treatment were what 
insulin is, benefits on insulin, types of insulin, blood glucose target and etc. Benefits of insulin. 
The prior participants' knowledge and attitudes regarding diabetes are explored by using question 
and discussion cards. The facilitator will guide the participants throughout the discussion. The 
facilitator that had been trained will read the cards out to stimulate an interactive participant 
discussion. The myths regarding diabetes are read aloud then the topics are discussed in the group 
and then the true fact will be presented in a clear, proper and concise way. During the first year 
after it was launch, the DCM had been successfully distributed to 68 countries across the world in 
31 different languages including malay language that is used for this study (Interactions, 2015). 
                In 2010, the similar DCM by Eli Lily® were introduced in Sub-Saharan Africa.  The 
training for educators on the usage of the DCM had been done in Nigeria, in August 2010. After 
the training had been done, the DCM were equally distributed to all district of the country and 
slowly it was being introduced into education programs involving diabetes. A study on the usage 
of the DCM in their environment was done . Among Nigerian, the level of acceptance on DCM 
usage was high especially in the northern regions area, where the muslims actually lay the 
conversation map on the floor and they will sit together around it during the learning educational 
sessions(Chinenye and Young, 2013).  
              In Malaysia, DCM were introduced in the early 2008 by Eli Lilly® Company (Interactions, 
2015). Recently, in year 2012, the complete set was translated into malay language. Since then, it 
has been used throughout the country. From a study done in Malaysia, they mention that the 
Ministry of Health of Malaysia has conducted the training courses on using DCM for diabetes 
nurse educators and is estimated that around 900 diabetes nurse educators have been trained fully 
on the DCM and had been practising it in both primary care and hospital-based diabetes care 
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(Hussein et al., 2015) . In ensuring good impact of DCM, the Eli Lilly ® Company have also done 
training for facilitator of DCM throughout the country. 
            In University Sains Malaysia Hospital (HUSM), the DCM were used since year 2012. It 
was use in Diabetes centre and Klinik Rawatan Keluarga. The DCM that were available were in 
malay language and the topics were living with diabetes, how diabetes works, healthy eating in 
diabetes, starting insulin treatment and ramadan with diabetes. Adequate training had been done 
by the Eli Lilly® Company to the diabetes educator in HUSM . 
           Training is needed for a diabetes educator to become a facilitator for DCM group education. 
In a survey that was conducted among the earliest educators that had experience on using the DCM, 
one of them had reported that to act as a facilitator compared to an educator that she was used to 
be is not an easy task. She also informs that she found it is hard to just listen to the participants 
during the sessions as the participants go through the DCM and had to prevent herself from giving 
out the correct answer about the queries immediately. A few numbers of other educators also 
reported negative experiences using the DCM. These restrictions include reluctance or unwilling 
to open up to the discussion by some participants, lack of space and occasionally there were 
personality clashes among the participants (Belton, 2008). 
              In another study name IDEA study, they mention that it is important to train the educators 
as facilitator before or prior using the DCM for group education (Fernandes et al., 2010). 
Facilitators with inadequate training may deliver less effective consultation which will reduce the 
effectiveness of the DCM. This was noted in a study, where they found that patients who went for 
group education using DCM had poor glucose control compared to individual education and from 
that they have concluded that there were possible lack of training of the facilitator in the study that 
have effect the result (Sperl-Hillen et al., 2011).  
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2.2.1 Impact of DCM             
            A study which was name as an IDEA study which is (Interactive Dialogue to Educate and 
Activate) was done aiming to investigate the effectiveness of the DCM as an important tool for 
education in diabetes compared with individual education or usual care and it have resulted in 
improvement in diabetes self-care management in DCM group (Fernandes et al., 2010).  
          Another study was done in Italy showed that diabetic patient who attended a course using 
DCM group education had an improvement in HbA1c and body mass index (BMI) comparing to 
individual education (Ciardullo et al., 2010). While in another study, where they compared DCM 
to the American Association of Diabetes Educators curriculum, they found out that blood glucose 
level improved in group education using DCM compared to the usual curriculum  (Zheng et al., 
2014).  
           One recent study among T2DM patient using DCM  in group discussion resulted in 
significant improvement in diabetes knowledge for the DCM  group comparing to regular care 
(Penalba et al., 2014). 
         However, there was a study done among spanish and germany comparing DCM group 
education and standard care where in their study they concluded that clinical outcomes such as 
Hba1c and lipid level were noted to be improved in six months within both groups (Reaney et al., 
2013). Besides that study, there was another study done showed that individual education resulted 
in better improvement of glucose control level compared to DCM  (Sperl-Hillen et al., 2011). 
          Based on the research findings mention above, both group and individual education for 
diabetic patients have a positive impact in clinical outcomes; but, a group education seems to be 
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able to provide care to a large number of people with T2DM together and approximately able to 
reduce human resources requirements.  
          For busy health centres, group education is the most practical approach in the setting (Mash 
et al., 2008). Even though in most of the public hospital setting, the group-based diabetes education 
is not yet well established, however in our country, group-based diabetes education using the DCM 
endorsed by the International Diabetes Federation has been used widely throughout the country 
ever since the complete set was translated into malay version (Hussein et al., 2015). 
             However, although many groups and individual educational materials are available, the 
relationship or interactions between patient and healthcare provider is recognised to have a positive 
influence on patient understanding, knowledge and adherence to treatment (Stewart, 1995). 
            Basically, all diabetes education should include all aspects of knowledge that should be 
delivered to the patient. Based on Malaysia guideline on management of type 2 diabetes mellitus, 
the content of education given should consist of exercise, diet, medication and complications 
including acute and chronic, self-monitoring blood glucose, foot care, the hazard of smoking, and 
psychosocial approach to diabetes (MOH, 2015). As for this study, the education will be more 
focus on medication, particularly on insulin initiation using the DCM. 
2.3 Insulin  
2.3.1 Insulin initiation          
               Achieving good glycaemic targets in T2DM patients has been a great challenge for both 
healthcare providers and patients. Many studies done have revealed that nearly one-third to one-
half of diabetic patients worldwide succeed in achieving HbA1c level less than 7% (53 mmol ⁄ 
mol) (Steinberg et al., 2008; Tong et al., 2008). The management of the diabetes disease is 
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complicated by the progressing nature of the disease as β cell function will decline, oral 
hypoglycemic medications alone are usually inadequate in maintaining good glycaemic control 
and insulin treatment is usually required at this stage. 
              Early use of insulin therapy in the management of uncontrolled diabetes has been 
recommended in preventing and reducing the long-term diabetes complications (Vinik, 2007; 
Westphal and Palumbo, 2006). According to Malaysia guideline on management of type 2 diabetes 
mellitus, all diabetic patient who have Hba1c >8% should be started on insulin therapy(MOH, 
2015). 
            However, delay in starting insulin therapy is common worldwide (Goodall et al., 2009; 
Nichols et al., 2007; Rubino et al., 2007). It is estimated that 50% of poorly control diabetic 
patients did not start insulin therapy at the proper time and the starting insulin was noted to be 
three to five years after the failure of oral hypoglycemic medications (Nichols et al., 2007; Rubino 
et al., 2007). From Karel Kostev et all, in a primary care practices in three European countries 
(Germany, France, UK), a patient with T2DM who had already been diagnosed to have 
macrovascular or microvascular complications, they were more likely to have insulin initiated 
(Kostev and Rathmann, 2013). 
           Standard treatment guidelines recommend that physicians should augment their patient's 
oral hypoglycemic medication with insulin injections after ensuring optimal adherence towards 
oral treatment. There was a study done in Cape Town city noted that barriers towards insulin 
initiation therapy include reduce knowledge about insulin among doctor, reduce experience with 
the use of insulin, lack of guidelines on how to prescribed insulin therapy, language barriers among 
patients and afraid that insulin will cause hypoglycemia to the patient. In the same study, the 
doctors also addressed their own opinions on what they thought patient barriers to be. They 
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concluded that misunderstanding about insulin therapy, the concerns about unable to comply to 
the medication given, reduce in the understanding of the diabetes disease, a favour to use 
traditional herbs, afraid or fear to use injections and the last poor socio-economic status. The same 
study also identified barrier in the system where they found that lack of time, inadequate continuity 
of care and financial constraints. However, in the study, they acknowledged that the important or 
major limitation involving the patients' perceptions were not elicited (Haque et al., 2005).  
            Lagging in starting insulin by physicians was supported by Muharrem AK et al, where 
almost half of the physicians in the study felt they were incompetent in starting insulin treatment 
and dosage adjustment. About 40.2 %  of the participants also felt incompetent in adjusting and 
maintaining insulin dosage (Ak et al., 2015). Training programme on insulin initiation that was 
organised in the study of Jeremy Dale at all, reveal that general practitioner who voluntarily 
attended the training programme and applies it as everyday practice for the poorly controlled 
diabetic patient, the impact on glycaemic control is not worsening over 3 years (Dale et al., 2010). 
               In clinical practice, initiating insulin therapy is commonly met with reluctance. One of a 
study conducted in United State of America(USA) revealed that 33% of insulin-naıve T2DM 
patients were not willing to start insulin treatment despite their uncontrolled diabetes (Larkin et 
al., 2007), while there was another study done amongst bangladeshi stated that out of that 42.5% 
of patients with T2DM were  not willing to start insulin treatment at the beginning but later they 
accepted insulin as their treatment, while 20.3% refuse to be started on insulin even after repeated 
counselling (Khan et al., 2008) .  
             Refusal towards insulin treatment is a complicated problem, and patients commonly have 
barriers in starting insulin. Apparently, many studies exploring perception and attitudes towards 
insulin treatment have been carried out among non-Asian patient populations. There is insufficient 
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information about the prevalence of insulin refusal among Asian patient populations and their 
perceptions towards insulin treatment. This was covered by a study done in Singapore where the 
results revealed a high prevalence of insulin refusal in their study population (70.6%).  
         While, according to Polonsky et all, data showed that less than 20% of diabetic patients are 
truly not willing to start insulin treatment despite counselling given (Polonsky et al., 
2005).Conclusion on insulin refusal has been noted to be a significant problem in Asian with 
T2DM (Wong et al., 2011). Overall, there are multiple factors contributing to delayed insulin 
initiation which it may be either from the patient, doctor or the system itself.  
2.3.2 Factors associated with insulin refusal 
                  Multiple barriers or factors have been noted contributing to patient non-acceptance to 
insulin. One of the studies reviewed that, fear of injections and needles and belief that insulin 
therapy would create difficulty for them to fulfil responsibilities at work and home (Woudenberg 
et al., 2012). While in another study, barriers noted were the perception that needed for insulin 
treatment in their diabetes was an indicator that their condition is serious and deteriorating. 
Another perception of thought that insulin treatment will lead to early age death was also one of 
the barriers to starting insulin. Other than that, fears of hypoglycaemia, weight gain, poor 
perception of benefits in improving glycaemic controlled and concern over frequent 
injections(Wong et al., 2011). From one study, they found out that a lack of adequate information 
relating to insulin appears to be the major factor behind diabetic patients’ refusal of insulin 
treatment. The fact that patients consider insulin treatment as a final solution to diabetes disease 
could be related to resistance to the initiation of insulin therapy (Ak et al., 2015). 
                  A comparison study was conducted between "acceptors" and "refusers" of insulin 
treatment in primary care clinics in Singapore. The RETHINK (Reconsider Therapy with insulin 
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knowledge) study revealed that acceptors had less concern about insulin injection compared to 
refusers. Another important barrier noted to initiate insulin was an idea of the significant pain 
would occur with the injections (Tan et al., 2003). 
                   In a study in Cape Town, doctors also inform regarding their opinions on what they 
think the patient barrier could be. They included of having the wrong idea about insulin, the 
concern about unable to comply to insulin, lack of knowledge in diabetes, a favour to use 
traditional herbs compare to normal medications, afraid of injections and poor socio-economic 
status (Haque et al., 2005).    
                 The term "psychological insulin resistance" has been introduced. They refer it to a 
negative attitude towards insulin treatment which will contribute to unnecessarily prolong delays 
in starting insulin (Polonsky et al., 2005). In this issue involving of psychological resistance, the 
DAWN (Diabetes Attitudes, Wishes and Needs ) study was conducted, in which a big number of 
the psychosocial survey was undertaken involving 5 000 diabetic patients and 4 000 healthcare 
workers throughout 13 countries. This study resulted that healthcare workers delayed the starting 
insulin treatment until they considered it necessary to the patient (Alberti, 2002). 
                All attitudes belief should be sought out and corrected. A study done at Public Health 
clinic in Malaysia concluded all the attitude belief about insulin therapy among patient resistance 
insulin and insulin acceptance. Among the barriers found were the feeling of personal failure if 
they were to be start on insulin therapy, 64.9% of patient-reported this as a factor making them 
resistant from taking insulin. However, the statistical analysis showed p-value was not significant 
p<0.006. Injecting is embarrassing (64.9%) and injecting insulin is painful (60.5%) were 
significantly deterring the patient from using insulin with a p-value of <0.001. Other significant 
factors suc as fear of problematic hypoglycemia, lack of fairness, restrictiveness and don't have a 
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regular time for a regular dose of insulin were the barriers identified. Interestingly,there was also 
barrier such as feeling like a drug addict if  they were to be treat with insulin therapy and 37.6% 
of patient reporting this (Nur Azmiah et al., 2011). 
2.3.3 Factors associated with insulin acceptance 
                 Not many studies have been done to see factors associated with insulin acceptance. 
According to the previous PIR studies, they noticed that the insulin-naïve T2DM patients who 
were more ready to accept insulin initiation were males. This study was done in Singapore where 
males were more ready to be started on insulin treatment (OR 2.0, CI 1.2–3.4 ) (Wong et al., 
2011).There was no explanations given on this in the study.  
               Furthermore, in the same study, they also revealed an important associated factor 
between educational level and willingness to accept insulin. They found that patients with tertiary 
education were more prepared to accept insulin treatment than patients in primary or secondary 
school education (OR3.3, CI 1.8–6.1).  A plausible explanation is given in this study where they 
found presence of differences in the perceptions of insulin between the educational groups which 
possible influencing their willingness in accepting insulin therapy. 
             Moreover, they also explain that usually, patients with lower levels of education will easily 
accept insulin therapy and commonly less fear to a daily lifestyle, responsibilities and inability to 
inject insulin properly. However, in their study, the significant differences in perceptions of 
insulin, suggest that participants with lower levels of education were more concerned with their 
lifestyle changes and technical aspects of the insulin treatment and cause them to refuse insulin 
therapy (Wong et al., 2011). 
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              In addition to gender and educational level, having relative use insulin is one of an 
important associated factor for insulin acceptance. As we know family history is a well-known 
associated factor for a diabetic patient. Family histories include inherited genetic susceptibilities 
and shared environments. This actually includes cultural factors such as preferences, idea and 
values, and perceptions and behavioural factors including diet and physical activity. A study that 
has been conducted found out that those who have insulin-using relatives and more diabetes-
related complications are noted to be factors influencing them for insulin acceptance (Morris et 
al., 2005; Woudenberg et al., 2012). In other words, we can say that having a history among the 
family members with chronic disease might influence their relative behaviour and perception 
towards the disease.  
          There was a study done among African American adults where in the study they found that 
having a positive family history of diabetes increased awareness about risk factors in diabetes and 
engaging them in better health behaviors among participants (Baptiste-Roberts., 2007). This was 
explained by possible of having the family history of chronic disease will influence their concerns 
and belief about the disease and its complications. Another study done on insulin acceptance 
resulted that those who accept insulin initiation was influenced by their perceptions about diabetes 
and insulin (Guimarães et al., 2010). 
           As we know, insulin is the most efficient therapy to lower down the blood glucose level 
and, due to its’ progressive nature of T2DM, many people with T2DM will subsequently require 
insulin therapy to attain and sustain adequate glucose control. Unfortunately, as we discussed 
above, in clinical practice, starting insulin treatment is commonly delayed in many patients with 
T2DM who actually would cater more benefit from such treatment. The uncontrolled glycemic 
burden and not receiving insulin treatment appropriately will lead the diabetic patient to have a 
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higher risk of macrovascular and microvascular complications. Indeed, in  IMPROVE study they 
found that poor glycemic control and high rates of vascular complications were observed at 
baseline in 51,286 diabetic patients that were enrolled in the study, where in the study they assessed 
the safety  and effectiveness of biphasic insulin aspart 70/30 in diabetic patients who required 
insulin treatment (Valensi et al., 2008). The belief and their concern about complications of 
uncontrolled diabetes and probable side effects of other treatment regime had influenced them in 
accepting insulin among the participants. Their strong belief in benefits of insulin and its' 
effectiveness was due to having a good knowledge regarding diabetes and insulin and also having 
their own self experience. Doctors' assessment and empathy support also helped them in accepting 
insulin treatment. These factors indirectly allayed their negative thought, concerns and beliefs 
about diabetes and insulin, which were their initial barriers towards insulin acceptance. (Hassan et 
al., 2013). 
             Those who were revealed to have more positive perceptions towards insulin treatment in 
the sense of its effectiveness in improving their glycaemic control and general health and also 
preventing diabetes complications were more ready to accept insulin (Morris et al., 2005; 
Woudenberg et al., 2012). Knowing that insulin is beneficial is an important factor for a diabetic 
patient to accept insulin treatment (Guimarães et al., 2010; Morris et al., 2005). The expectation 
and understanding among diabetic patients that good glycaemic control will improve their health 
and well-being will also increase their perception towards insulin treatment (Guimarães et al., 
2010; Nair et al., 2007). A study done among Pakistani revealed that the insulin perception was 
higher in patients with a higher monthly income  (p < 0.001) (Saleem et al., 2016).   
             From a study by Morris et al. (2005), the patient with T2DM recognised insulin as a 'friend' 
or 'foe'. This recognition will influence their acceptance towards insulin therapy. The experiences 
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of using insulin gave them the rationale about the benefits of the insulin and subsequently influence 
them in accepting insulin as 'a friend'. The experiences increase their confidence towards using 
insulin by knowing that they were able to inject themselves and adjust the insulin dosage 
themselves. This allowed demonstration of insulin therapy efficacy when better glycaemic control 
and well-being were achieved, thus indirectly validate their perception towards insulin benefits 
(Morris et al., 2005). 
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2.4 Conceptual framework 
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CHAPTER 3: OBJECTIVES & HYPOTHESIS 
3.1 Research Question  
The study will investigate the following research questions: 
1. What is the percentage of insulin acceptance between those receiving group education using 
DCM comparing to standard individual education among insulin refusal? 
2. What are the associated factors for their acceptance of insulin? 
3.2 General Objective: 
To compare the percentage of insulin acceptance between the intervention group (those who 
receive DCM education) and control group (those who receive standard individual education) and 
the associated factor of insulin acceptance among insulin refusal attending Klinik Rawatan 
Keluarga HUSM. 
3.3 Specific objectives  
1. To compare the percentage of insulin acceptance between intervention (those who receive 
DCM education) and control group (those who receive standard individual education). 
2.         To determine the associated factor of insulin acceptance among insulin refusal. 
3.4 Research Hypothesis  
The percentage of insulin acceptance is higher in those receiving group education using DCM 
compared to those receiving standard individual education. Socio-demographic, having relative 
of use insulin and having comorbidities are significant associated factors of insulin acceptance.   
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CHAPTER 4: METHODOLOGY 
This study consist of two phases. Phase one which to study objective one was done in randomize 
control trial design whereas in phase two to study objective two was done in cross sectional 
study design. 
4.1 Phase one Study 
4.1.1 Study Design 
This is a prospective, parallel group and open randomised control trial. 
The participants were assigned into 2 groups via computer-generated block randomisation.1 group 
will receive a group education using DCM (intervention group) while the other group will receive 
standard individual education (control group). 
4.1.2 Population and Sample 
4.1.2.1- Reference population 
The reference of the population is the uncontrolled T2DM patient in Kota Bharu 
4.1.2.2- Source population 
Uncontrolled T2DM patients attending Klinik Rawatan Keluarga ,HUSM, Kubang Kerian, Kota 
Bharu, Kelantan 
4.1.2.3- Study population 
Uncontrolled T2DM patient who refused insulin treatment attending Klinik Rawatan Keluarga, 
HUSM, Kubang Kerian, Kota Bharu, Kelantan 
